Acute gastroenteritis linked to higher rates of irritable bowel syndrome and functional dyspepsia

FHS
July 18, 2024
5:48 am

Researchers examine the prevalence of post-infectious irritable bowel syndrome and post-infectious function dyspepsia following acute gastroenteritis.

Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19 – Biotech Investments

Biophytis / Key word(s): Regulatory Approval Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of

September 20, 2023

The Biggest Psychedelic News This Week: November 6 – 10 | Psychedelic Spotlight

As researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization

November 10, 2023

As SQZ faced a final reckoning, a fateful board decision steered the company to a quick and brutal endgame

A decade after SQZ was birthed amid considerable enthusiasm and midwifed by one of the biggest scientific stars in Cambridge, MA, the few survivors of

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.